Regulation 249 Restrictions on persons to be supplied with medicinal products

(1)

The holder of an authorisation of the kind referred to in paragraph (2) may not sell a prescription only medicine or a pharmacy medicine by way of wholesale dealing to a person who does not fall within a class specified in Schedule 22.

(2)

Those authorisations are—

(a)

a F1UK marketing authorisation;

F2(aa)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(b)

a certificate of registration;

(c)

a traditional herbal registration; and

(d)

an Article 126a authorisation.

(3)

A person may not, in the course of a business consisting (wholly or partly) of manufacturing medicinal products or of selling medicinal products by way of wholesale dealing, sell a prescription only medicine or a pharmacy medicine by way of wholesale dealing to a person who does not fall within a class specified in Schedule 22.

(4)

This regulation is subject to regulation 250.

Annotations

Textual amendments

F1: Word in reg. 249(2)(a) inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 194(a); 2020 c. 1, Sch. 5 para. 1(1)
F2: Reg. 249(2)(aa) omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 107

Notes on Part 12

Modifications

C1: Pt. 12 modified (E.W.) (1.10.2015) by The Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015 (S.I. 2015/895), regs. 1(3), 4(2)